Low Back Pain, Low Level Laser Therapy, Neuropathic Pain, Nociceptive Pain, Pain
Conditions
Keywords
Low Level Laser Therapy, Low Back Pain, Diagnosis, Genetic, Clinical trial
Brief summary
Chronic axial low back pain is a public health problem and has a high socioeconomic impact. The dorsal ganglion of the second spinal nerve (GDL2) is a cluster of neuronal bodies responsible for sensory afferent inputs from more than 80% of the lumbar region. Low-level laser therapy (LLLT) is proven effective to help relieve pain. Thus, the aim of this project is to determine the effect of LLLT on GDL2 when applied to assist in the diagnosis and treatment of chronic axial low back pain. Methodology: 45 patients will be randomized into three groups: laser, radiofrequency and local anesthetic. The patient will be positioned in a prone horizontal position under anesthetic monitoring. The intervertebral foramen between the second and third lumbar vertebrae will be accessed by percutaneous puncture guided by fluoroscopy. In the local anesthetic group, injection of 1 ml lidocaine without vasoconstrictor will be applied in the tubes G20, 150 mm long and 5 mm active tip in contact with the target. In the radiofrequency group, neuromodulation will be held for 300 seconds at 42oC. In the laser group, the laser Photon III® (DCM) will be applied through optic fiber crossing G18 cannulas, during 84 seconds. The pain score will be assessed by visual analog scale. Temperature will be measured and aspirate periganglionic sample, trans-operatively, to study Interleucins-1β and TNF-alpha assessed by ELISA and genetic evaluation trough RNA seek, RNA isolation and ATP quantification. The data will be evaluated for normality and subjected to appropriate statistical analysis, in order to seek representation, as same as the level of significance of the studied samples.
Interventions
PROCEDURELaser
Low level laser therapy will be delivered through Laser Photon III ® (DMC) in the second lumbar dorsal root ganglion.
PROCEDUREDrug: Lidocaine
1 mL of Lidocaine will be delivered in the second lumbar dorsal root ganglion through fluoroscopy.
PROCEDURERadiofrequency
Radiofrequency will be delivered during 300 seconds, 42oC in the second lumbar dorsal root ganglion.
Sponsors
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
University of Nove de Julho
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* Chronic low back pain (more than 3 months of nociceptive or neuropathic pain). * No neurological deficits
Exclusion criteria
* Active lumbar cancer * Active infection * Coagulation disorders
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Intensity Measure using Visual Analog Scale | 5 minutes before procedure | Self reported pain intensity following Visual Analog Scale, scored 0-10 (0=no pain; 10=the worst pain ever). |
| Pain Intensity Measure using the change in Visual Analog Scale from baseline at 1 month | 5 minutes after procedure | Patients will report the intensity of the pain using the score in visual analogue scale, scored 0-10 (0=no pain; 10=the worst pain ever). |
| Pain Intensity Measure using the Visual Analog Scale | 1 month and 6 months after procedure | In follow up, patients will report the intensity of the pain using the score in visual analogue scale, scored 0-10 (0=no pain; 10=the worst pain ever). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Immunochemistry to analyse IL-1, IL-10, TNF alfa. | Samples collected 1 minute after the application of laser, radiofrequency or lidocaine | Through the needle used the sample will be collected and examined by immunocytochemical staining and ELISA. |
Countries
Brazil
Outcome results
None listed